Evidence map›Paper›PMID 25320082›Full record

ArticleThe Journal of biological chemistry2014

Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.

Uwe Kirchhefer, Christiane Brekle, John Eskandar, Gunnar Isensee, Dana Kučerová, Frank U Müller, Florence Pinet, Jan S Schulte, Matthias D Seidl, Peter Boknik

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Targeting PP2A in cancer: an underrated option.Journal of experimental & clinical cancer research : CR · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Downregulation of protein phosphatase 2Aα in asthmatic airway smooth muscle.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  7. Article
  8. Lysergic acid diethylamide stimulates cardiac human HNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  9. Article
  10. Role of CaArchives of toxicology · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Targeting PP2A in cancer: Combination therapies.Biochimica et biophysica acta. Molecular cell research · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Uwe KirchheferFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and kirchhef@uni-muenster.de.
Christiane BrekleFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
John EskandarFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Gunnar IsenseeFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Dana KučerováFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Frank U MüllerFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Florence PinetINSERM, U744, Institut Pasteur de Lille, 59019 Lille, France.
Jan S SchulteFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Matthias D SeidlFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
Peter BoknikFrom the Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, D-48149 Münster, Germany and.
University Hospital Münster · DEInstitut Pasteur de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dephosphorylation of important myocardial proteins is regulated by protein phosphatase 2A (PP2A), representing a heterotrimer that is comprised of catalytic, scaffolding, and regulatory (B) subunits. There is a multitude of B subunit family members directing the PP2A holoenzyme to different myocellular compartments. To gain a better understanding of how these B subunits contribute to the regulation of cardiac performance, we generated transgenic (TG) mice with cardiomyocyte-directed overexpression of B56α, a phosphoprotein of the PP2A-B56 family. The 2-fold overexpression of B56α was associated with an enhanced PP2A activity that was localized mainly in the cytoplasm and myofilament fraction. Contractility was enhanced both at the whole heart level and in isolated cardiomyocytes of TG compared with WT mice. However, peak amplitude of [Ca]i did not differ between TG and WT cardiomyocytes. The basal phosphorylation of cardiac troponin inhibitor (cTnI) and the myosin-binding protein C was reduced by 26 and 35%, respectively, in TG compared with WT hearts. The stimulation of β-adrenergic receptors by isoproterenol (ISO) resulted in an impaired contractile response of TG hearts. At a depolarizing potential of -5 mV, the ICa,L current density was decreased by 28% after administration of ISO in TG cardiomyocytes. In addition, the ISO-stimulated phosphorylation of phospholamban at Ser(16) was reduced by 27% in TG hearts. Thus, the increased PP2A-B56α activity in TG hearts is localized to specific subcellular sites leading to the dephosphorylation of important contractile proteins. This may result in higher myofilament Ca(2+) sensitivity and increased basal contractility in TG hearts. These effects were reversed by β-adrenergic stimulation.

Indexed as

Adrenergic beta-AgonistsAnimalsCalciumCalcium-Binding ProteinsCarrier ProteinsCells, CulturedGene Expression RegulationHeartIsoproterenolMembrane PotentialsMiceMice, Inbred DBAMice, TransgenicMyocardial ContractionMyocytes, CardiacMyofibrilsAdrenergic beta-AgonistsCalciumCalcium-Binding ProteinsCarrier ProteinsIsoproterenolMyosin Binding Protein CPhospholambanPpp2r5a protein, mouseProtein Phosphatase 2Troponin IAdrenergic ReceptorCardiomyocyteContractile ProteinProtein Phosphatase 2 (PP2A)Protein Phosphorylation

Identifiers

PMID25320082
PMCPMC4256322
OpenAlexW2033587029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.